Genmab — April 2018
-
God morgen

-
Shorterne har opført sig meget humant i Genmab. Vi har ikke set deciderede "angreb" på svage dage for at udløse stoploses og panik.
-
Netop bibob.
-
Det er vist et hængeparti efter de tekniske problemer i går.
-
Novartis expects completion Arzerra iNHL trial to complete Q2-2018 with a publication Q4 https://clinicaltrials.gov/ct2/show/NCT01077518 p64
https://clinicaltrials.gov/ct2/show/NCT01077518 -
https://www.novartis.com/sites/www.novartis.com/files/q1-2018-ir-presentation.pdf presentation link again p64
-
Udbudspriser har ikke været stillet i længere tid.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
